Nathalie Brandenberg and Sylke Hoehnel co-founded SUN bioscience in 2016. SUN bioscience offers a 3D microwell platform based on patient-specific organoids. Organoids are self-organizing 3D miniature tissues with organ-mimicking functions that are grown from stem cells. The challenge? Allowing patients suffering from various diseases to identify the treatments that are best suited to them – a revolution in personalized medicine. Nathalie Brandenberg and Sylke Hoehnel both graduated from EPFL’s School of Life Sciences. They are the co-CEOs of the company.

5:30 pm
Allocution de bienvenue                                                                                                                           Leïla Ojjeh, EPFL Alumni Director

5:35 pm
Introduction
Prof. Gisou van der Goot, Vice President for Responsible Transformation and Head of Laboratory of Cell and Membrane Biology

5:40 pm
Campus Lecture
“On the Verge of the Next Healthcare Revolution”
Nathalie Brandenberg, co-CEO & Founder, SUN bioscience
SV’11, PhD SV’17
Sylke Hoehnel, co-CEO & Founder, SUN bioscience
PhD SV’15

6:15 pm
Q&A

6:30 pm
Cocktail